Effect of Shoulder Sling Use on Balance and Mobility in Subacute Stroke Patients
Launched by ARNAOUTIS STYLIANOS · Mar 29, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether wearing a shoulder sling can help improve balance and mobility for people recovering from a stroke. The researchers want to see if the sling makes patients feel more stable and safe when they walk and do everyday activities. Participants will take part in simple movement and balance tests—once while wearing the sling and once without it—to compare the results.
To join the study, participants should be between 40 and 80 years old and have had a stroke within the last six months that affects one arm. They should be able to follow simple instructions and be medically stable enough to take part in the tests. However, people with severe cognitive issues, certain vision or balance disorders, or other serious health problems may not be eligible. If you or a loved one fits these criteria, this trial could provide valuable insights into improving daily life after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of stroke in the subacute phase (up to 6 months post-onset)
- • Hemiplegia affecting one upper limb
- • Brunnstrom stage \< 4 for the affected upper limb
- • Functional Ambulation Category (FAC) score \> 3
- • Age between 40 and 80 years
- • Ability to follow simple instructions
- • Medically stable to participate in balance and mobility testing
- • Signed informed consent
- Exclusion Criteria:
- • Severe cognitive impairment (e.g. MMSE \< 23)
- • Visual or vestibular disorders affecting balance
- • Significant orthopedic or musculoskeletal conditions of the lower limbs
- • Uncontrolled cardiovascular or pulmonary disease
- • Use of assistive devices that prevent sling application
- • Severe aphasia interfering with understanding or communication
- • Skin lesions or injuries at the shoulder region preventing sling use
About Arnaoutis Stylianos
Arnaoutis Stylianos is a dedicated clinical trial sponsor committed to advancing medical research through innovative studies and rigorous scientific methodologies. With a focus on enhancing patient outcomes and developing effective therapeutic solutions, the organization collaborates with healthcare professionals and research institutions to conduct clinical trials across various therapeutic areas. Leveraging a comprehensive understanding of regulatory requirements and ethical considerations, Arnaoutis Stylianos strives to uphold the highest standards of safety and efficacy in all its clinical endeavors, ultimately contributing to the improvement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Koropi, Attica, Greece
Patients applied
Trial Officials
Nikolaos Chrysagis
Study Chair
University of West Attica
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported